Regulacje i polityka gospodarcza · 29/11/1995
Bristol Myers Squibb to Grant Exclusive Patent License to Third-Party Company
Bristol Myers Squibb announces its intent to grant an exclusive patent license to a third-party company, allowing the latter to develop and commercialize a specific pharmaceutical product.